APPLICATION
ANDA214177
TYPE
ANDA
ORIGINAL APPROVAL
2025-03-14
LATEST ACTION
2025-03-14
ROUTE
RESPIRATORY (INHALATION), INHALATION, ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ACETYLCYSTEINEPrescription
ACETYLCYSTEINE 10% · SOLUTION · INHALATION, ORAL
ACETYLCYSTEINEPrescription
ACETYLCYSTEINE 20% · SOLUTION · INHALATION, ORAL
Approval history
2025-03-14UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.